All Articles

Applying cryopreserved amniotic membrane following intravitreal injection

CAM encourages corneal healing in patients with ocular surface disease.

No ocular manifestations associated with inflammatory bowel disease, study finds

In a study, investigators found that no characteristics of inflammatory bowel disease are related to ocular manifestations of the disease.

Phase 3 study of CPN-302: Positive topline results for post-cataract surgery drug candidate

The companies note that data from Study CPN-302 confirm the results in the first Phase 3 study, CPN-301, and they demonstrate the clear benefits of treating patients after cataract surgery with APP13007.

Intravenous bevacizumab repackaged for intravitreal use: Making the sight-saving treatment safer

August 10, 2022

Although off-label repackaged bevacizumab syringes appear to satisfy an urgent clinical and financial need for patients with a variety of retinal disorders, they are known to be associated with considerable public health concerns due to the risks posed to patients from compounding pharmacies’ lack of compliance with a variety of FDA requirements.

The need for precision management in glaucoma moves field forward

August 08, 2022

Genotyping and artificial intelligence are together starting to predict the progression of glaucoma in individual patients, sparing them from suboptimal treatments and side effects. Recent research efforts are exploring modifiable risk factors such as caffeine consumption.

High-tech, noninvasive imaging identifies early glaucoma

August 06, 2022

Flavoprotein fluorescence could serve as a new biomarker, according to a Mount Sinai study. This measurement could potentially be used as a first-line indicator to monitor of glaucoma progression for the patient and the physician.